Magenta Medical

About Magenta Medical

Magenta Medical is focused on developing innovative medical devices for cardiovascular support, specifically aimed at assisting patients undergoing high-risk coronary interventions and those with cardiogenic shock.

Products & Services

Elevate™ percutaneous Left Ventricular Assist Device (pLVAD):A low-profile, high-flow arterial pump designed for temporary support of patients during high-risk coronary interventions and for treatment of cardiogenic shock.

Specialties

Percutaneous Mechanical Circulatory Support Cardiovascular Interventions Cardiogenic Shock Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Round T: - FT: Venture Round	A: 105000000 MR: - FA: $105M FAN: 105000000	D: 2024-07-23 FD: 2024-07-23	7 investors
2	RT: Financing Round T: - FT: Financing Round	A: 55000000 MR: - FA: $55M FAN: 55000000	D: 2023-05-03 FD: 2023-05-03	4 investors

Venture Round Latest

2024-07-23

$105.0M

7 investors (Pro only)

Financing Round 2023-05-03

$55.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Israeli

Chairman & CEO

E

Ehud Schwammenthal

MD, PhD - Co-Founder & CMO

Y

Yosi Tuval

Co-Founder & CTO

R

Rafi Beyar

Professor

D

David Bonita

Board Member

Z

Zeev Binman

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Magenta Medical Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised